Filter
1119
Text search:
epidemiological
profile
Featured
Recommendations
90
New Publications
333
Language
Document type
No document type
692
Studies & Reports
182
Guidelines
124
Strategic & Response Plan
50
Manuals
40
Fact sheets
15
Training Material
8
Situation Updates
6
Resource Platforms
2
Countries / Regions
India
64
Global
39
Western and Central Europe
30
Sierra Leone
29
Nigeria
25
Kenya
24
Ethiopia
23
Latin America and the Carribbean
22
Africa
20
South Africa
19
Eastern Europe
19
Ghana
17
Nepal
17
Liberia
16
Uganda
16
Zambia
16
Myanmar / Burma
15
Bangladesh
14
Malawi
14
Rwanda
13
Namibia
12
Philippines
11
Ukraine
11
Guinea
9
Pakistan
9
Tanzania
9
Mozambique
9
Brazil
9
Botswana
8
Afghanistan
7
Syria
7
South–East Asia Region
7
Asia
7
Indonesia
6
Benin
6
Russia
6
Senegal
5
Congo, Democratic Republic of
5
Zimbabwe
5
Haiti
5
Cambodia
5
East and Southern Africa
5
West and Central Africa
5
Paraguay
5
Venezuela
5
Somalia
4
Peru
4
Colombia
4
Madagascar
4
Cameroon
3
Germany
3
Eswatini/ Swaziland
3
Ecuador
3
Bolivia
3
Lesotho
3
Yemen
3
Middle East and North Africa
3
Western Pacific Region
3
Albania
3
North America
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Iraq
2
Lebanon
2
Chad
2
Thailand
2
Gambia
2
Argentina
2
Burundi
2
Eastern Europe and Central Asia
2
Tajikistan
2
Kyrgyzstan
2
Guinea-Bissau
1
Saudi Arabia
1
Togo
1
Jordan
1
Egypt
1
China
1
Ireland
1
Sudan
1
Central African Republic
1
North Macedonia
1
Libya
1
Guatemala
1
Sri Lanka
1
Bhutan
1
Palestine
1
Djibouti
1
Armenia
1
Southern Africa
1
Laos
1
Timor Leste/ East Timor
1
Qatar
1
Moldova
1
Iran
1
Georgia
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
447
Clinical Guidelines
118
Public Health
69
Women & Child Health
30
Key Resources
27
Capacity Building
13
Pharmacy & Technologies
12
Toolboxes
TB
105
COVID-19
85
HIV
82
Mental Health
80
Rapid Response
59
NTDs
49
NCDs
29
Ebola
28
Planetary Health
27
AMR
25
Zika
17
Polio
16
Disability
13
Refugee
13
Pharmacy
13
Global Health Education
12
Conflict
11
Cholera
10
Natural Hazards
7
Caregiver
7
Specific Hazards
4
Health Financing Toolbox
4
Social Ethics
1
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with
...
Glob Heart . 2020 Oct 13;15(1):69. doi: 10.5334/gh.891.
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons
...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from
...
This annual report highlights the work of the WHO from January to June 2021 ( December 2021). The activities featured herein are by no means exhausted but implemented with technical and financial support through WHO in Nigeria; facilitated by its presence at all levels of governance (national, state
...
La enfermedad de Chagas (ECha), resultado de la infección por el Trypanosoma cruzi, afecta varias poblaciones de las
zonas rurales de Suramérica y América Central. En los últimos años la enfermedad ha cobrado importancia epidemiológica no sólo porque se ha incrementado la detección de caso
...
Infectious disease outbreaks and epidemics are increasing in frequency, scale and impact. Health care facilities can amplify the transmission of emerging infectious diseases or multidrug-resistant organisms (MDRO) within their settings and communities. Therefore, evidence-based infection prevention
...
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but also for the need to understand the current funding
...
Climate change is already having severe impacts across our planet, bringing new and previously unimaginable challenges to the people least responsible for greenhouse gas emissions.
This report, the first we’ve released jointly in the history of our organizations, provides a sobering review of h
...
In 1997, the Fiftieth World Health Assembly adopted resolution WHA50.29 on the elimination of
lymphatic filariasis as a public health problem. Preliminary guidance from WHO printed in 2011 referred to “verification” as the official process by which the achievements of the Global Programme to El
...
The results of the report clearly show that in 2020, a year dominated by the emergence of COVID-19 and its associated health and economic crises, governments around the world rose to the challenge. Sharp increases in government spending on health at all country income levels underpinned the rise in
...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance
...
Countries, partners, and donors are committed to
the global elimination of blinding trachoma by 2020.
Achieving this public health milestone requires more
than funding; it requires health personnel with the
right mix of skills, and well supported and managed
health systems. Mass drug administra
...
This new guidance aims to support programme implementers, coordinators and others in humanitarian settings in their actions to counter suicide and self-harm in humanitarian contexts and to save lives.
PLoS Neglected Tropical diseases August 16, 2021 https://doi.org/10.1371/journal.pntd.0009697
Chagas disease, also known as American trypanosomiasis, is a neglected tropical disease transmitted by triatomine insects, first identified in 1909. Chagas disease affects approximately 6–7 million peop
...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan
...
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga
...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r
...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e
...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f
...
